Here, in mice engrafted with human PBMC we detected no significant increase in PD-L1 expression (FITC-conjugated anti-human CD274) in human cancer cells from mice given avelumab alone or SNS-032 plus avelumab (Figure 5C). The gene discussed is CD274; the disease is cancer.